vs

Side-by-side financial comparison of HERC HOLDINGS INC (HRI) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

HERC HOLDINGS INC is the larger business by last-quarter revenue ($30.1M vs $21.8M, roughly 1.4× NEKTAR THERAPEUTICS). NEKTAR THERAPEUTICS runs the higher net margin — -165.4% vs -331.7%, a 166.2% gap on every dollar of revenue. On growth, HERC HOLDINGS INC posted the faster year-over-year revenue change (629.3% vs -25.3%). HERC HOLDINGS INC produced more free cash flow last quarter ($-14.3M vs $-65.0M).

Herc Holdings Inc. is a leading North American equipment rental service provider. It offers rental assets including heavy construction machinery, power tools, temporary power and climate control systems, serving clients across construction, industrial, events, infrastructure and government segments, with operations across the U.S. and Canada.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

HRI vs NKTR — Head-to-Head

Bigger by revenue
HRI
HRI
1.4× larger
HRI
$30.1M
$21.8M
NKTR
Growing faster (revenue YoY)
HRI
HRI
+654.5% gap
HRI
629.3%
-25.3%
NKTR
Higher net margin
NKTR
NKTR
166.2% more per $
NKTR
-165.4%
-331.7%
HRI
More free cash flow
HRI
HRI
$50.7M more FCF
HRI
$-14.3M
$-65.0M
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HRI
HRI
NKTR
NKTR
Revenue
$30.1M
$21.8M
Net Profit
$-99.9M
$-36.1M
Gross Margin
42.3%
Operating Margin
-77.4%
-126.9%
Net Margin
-331.7%
-165.4%
Revenue YoY
629.3%
-25.3%
Net Profit YoY
-866.2%
-596.9%
EPS (diluted)
$-0.36
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRI
HRI
NKTR
NKTR
Q4 25
$30.1M
$21.8M
Q3 25
$10.1M
$11.8M
Q2 25
$6.3M
$11.2M
Q1 25
$4.2M
$10.5M
Q4 24
$4.1M
$29.2M
Q3 24
$24.1M
Q2 24
$23.5M
Q1 24
$21.6M
Net Profit
HRI
HRI
NKTR
NKTR
Q4 25
$-99.9M
$-36.1M
Q3 25
$-7.5M
$-35.5M
Q2 25
$-10.8M
$-41.6M
Q1 25
$-14.1M
$-50.9M
Q4 24
$-10.3M
$7.3M
Q3 24
$-37.1M
Q2 24
$-52.4M
Q1 24
$-36.8M
Gross Margin
HRI
HRI
NKTR
NKTR
Q4 25
42.3%
Q3 25
25.8%
Q2 25
53.1%
Q1 25
35.0%
Q4 24
21.4%
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
HRI
HRI
NKTR
NKTR
Q4 25
-77.4%
-126.9%
Q3 25
-153.5%
-268.6%
Q2 25
-147.4%
-324.2%
Q1 25
-242.7%
-425.8%
Q4 24
-206.3%
49.2%
Q3 24
-142.4%
Q2 24
-211.9%
Q1 24
-163.7%
Net Margin
HRI
HRI
NKTR
NKTR
Q4 25
-331.7%
-165.4%
Q3 25
-74.1%
-301.3%
Q2 25
-171.4%
-372.2%
Q1 25
-332.8%
-486.4%
Q4 24
-250.3%
24.9%
Q3 24
-153.6%
Q2 24
-222.9%
Q1 24
-170.1%
EPS (diluted)
HRI
HRI
NKTR
NKTR
Q4 25
$-0.36
$-4.67
Q3 25
$-0.03
$-1.87
Q2 25
$-0.08
$-2.95
Q1 25
$-0.15
$-0.24
Q4 24
$-0.15
$-2.07
Q3 24
$-2.66
Q2 24
$-3.76
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRI
HRI
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$550.7M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$437.8M
$89.8M
Total Assets
$1.1B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRI
HRI
NKTR
NKTR
Q4 25
$550.7M
$15.1M
Q3 25
$432.8M
$41.0M
Q2 25
$67.6M
$43.0M
Q1 25
$38.9M
Q4 24
$30.0M
$44.3M
Q3 24
$30.1M
Q2 24
$27.9M
Q1 24
$48.6M
Total Debt
HRI
HRI
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$300.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HRI
HRI
NKTR
NKTR
Q4 25
$437.8M
$89.8M
Q3 25
$486.1M
$85.1M
Q2 25
$90.8M
$-24.2M
Q1 25
$26.1M
$13.7M
Q4 24
$16.6M
$60.7M
Q3 24
$48.9M
Q2 24
$79.7M
Q1 24
$126.7M
Total Assets
HRI
HRI
NKTR
NKTR
Q4 25
$1.1B
$280.4M
Q3 25
$550.2M
$301.3M
Q2 25
$152.0M
$207.5M
Q1 25
$104.6M
$256.2M
Q4 24
$109.6M
$303.9M
Q3 24
$308.0M
Q2 24
$343.3M
Q1 24
$396.0M
Debt / Equity
HRI
HRI
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.02×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRI
HRI
NKTR
NKTR
Operating Cash FlowLast quarter
$-12.7M
$-65.0M
Free Cash FlowOCF − Capex
$-14.3M
$-65.0M
FCF MarginFCF / Revenue
-47.6%
-298.0%
Capex IntensityCapex / Revenue
5.3%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRI
HRI
NKTR
NKTR
Q4 25
$-12.7M
$-65.0M
Q3 25
$-11.0M
$-48.8M
Q2 25
$-8.4M
$-45.7M
Q1 25
$-6.7M
$-49.1M
Q4 24
$-8.1M
$-46.2M
Q3 24
$-43.9M
Q2 24
$-37.7M
Q1 24
$-47.9M
Free Cash Flow
HRI
HRI
NKTR
NKTR
Q4 25
$-14.3M
$-65.0M
Q3 25
$-11.1M
$-48.9M
Q2 25
$-8.5M
$-45.8M
Q1 25
$-6.8M
$-49.1M
Q4 24
$-8.1M
$-46.6M
Q3 24
$-44.6M
Q2 24
$-37.9M
Q1 24
$-48.0M
FCF Margin
HRI
HRI
NKTR
NKTR
Q4 25
-47.6%
-298.0%
Q3 25
-110.2%
-414.5%
Q2 25
-135.5%
-409.6%
Q1 25
-160.8%
-469.0%
Q4 24
-197.1%
-159.9%
Q3 24
-184.9%
Q2 24
-161.3%
Q1 24
-222.0%
Capex Intensity
HRI
HRI
NKTR
NKTR
Q4 25
5.3%
0.1%
Q3 25
1.7%
1.0%
Q2 25
1.5%
0.3%
Q1 25
4.0%
0.0%
Q4 24
0.7%
1.6%
Q3 24
2.8%
Q2 24
0.8%
Q1 24
0.7%
Cash Conversion
HRI
HRI
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRI
HRI

Sales Of New Equipment$9.0M30%
Sales Of Parts And Supplies$8.0M27%
Other$7.1M24%
Serviceand Other Revenue$6.0M20%

NKTR
NKTR

Segment breakdown not available.

Related Comparisons